Abd Tahrani is a National Institute for Health Research (NIHR) Clinician Scientist at the University of Birmingham (UOB), and a Honorary Consultant Endocrinologist and Bariatric Physician at the University Hospitals Birmingham NHS Foundation Trust. Dr Tahrani is also the lead for weight management research and diabetic neuropathy services at Birmingham Heartlands Hospital and the lead for translation research in the Centre of Endocrinology, Diabetes and Metabolism and the communication co-lead at the Institute of Metabolism and Systems Research.
He leads a multi-disciplinary research group that include scientists, clinicians and allied health-care professionals. The aims of this research group are to:
- examine the impact of sleep-related disorders (including obstructive apnoea) on metabolic health, diabetes and obesity
- improve our understanding of the pathogenesis of diabetes-related microvascular complications (peripheral neuropathy, autonomic neuropathy, nephropathy, retinopathy) and to identify new treatment targets and effective screening strategies
- improve our understanding of the pathogenesis of foot ulceration in diabetes and develop new treatments
- explore the pharmacological and non-pharmacological options to treat and manage patients with obesity (including the long-term outcomes of bariatric surgery)
- develop new treatments for type 2 diabetes
Dr. Tahrani has published over 125 peer reviewed articles and book chapters and in excess of 150 abstracts. He is regularly invited to speak in many of the leading national and international conferences in USA, Europe and Asia.
Dr. Tahrani has won several national and international awards including SCOPE National Fellow from the World Obesity Federation in 2014, The Diabetes UK best primary care poster award 2014, NIHR Clinician Scientist award in 2013, the American Academy of Sleep Medicine Sleep Disordered Breathing investigator of the year award in 2013, The Sanofi Aventis Clinical Excellence Award in 2009, the Society for endocrinology presentations award 2009, and a NIHR personal research training fellowship in 2008 in addition to several regional and local awards. He was also nominated to the Nick Hales young investigator award by Diabetes UK and he was recently elected as a member of Neurodiab (The diabetic neuropathy group of the EASD).
He previously served on the clinical committee of The Society for Endocrinology and is currently the diabetes and metabolism section editor for BMC Endocrine disorders and an editorial advisor to BMC Obesity. He serves on the editorial boards of several journals and was the editorial consultant for the type 1 diabetes module of the American College of Physicians.
Dr Tahrani is a regular reviewer of grants submitted to several NIHR streams and the Hong Kong research council amongst others and a regular peer reviewer to several leading journals in the fields of medicine, endocrinology, diabetes and obesity
Dr. Tahrani is a member of the organising committee of the European Congress of Obesity 2019, a faculty member of the Neurodiab 2018 conference, a member of the NIHR RfPB and the NIHR Dissemination Centre. He also serves as an expert advisor to NICE. He was an examiner at the Royal College of Physicians in London.